新潟大学 · 教育研究院/教育学部

研究キーワード血液透析・高齢透析患者・健康関連QOL・介護保険利用・腎代替療法・クローン病・インフリキシマブ・アザチオプリン・医療経済評価

ここは公開データのプレビューです。個別の適合理由、連絡角度、保存機能はログイン後に利用できます。

• Conclusions: Combination therapy with IFX plus AZA appears to be a cost-effective treatment for drug-refractory CD when compared with IFX monotherapy. Furthermore, the additional lymphoma risk of combination therapy has little significance on its cost-effectiveness. (C) 2012 European Crohn's and Colitis Organisation. Published by Elsevier B.V. All rights reserved.2012 · 論文
• 0.001) showed significant negative correlations with the EQ-5D-5 L score. Conclusions: Reduced walking ability, and Anxiety and Depression, were associated with lower EQ-5D-5 L score and appeared to be important factors in decreasing health for older hemodialysis patients. These results suggest that patients’ families and dialysis facility staff should be trained in early detection of depression and that patients should maintain their walking ability by exercise therapy.論文
• researchmap論文
• 0.001), duration of hemodialysis (−0.175論文

• 公式プロフィール